Bookmark and Share
Australian Prescriber
  • Home
  • About us
    • Who we are
    • What we do
    • Editorial executive committee
    • Advisory editorial panel
    • AP Video
  • Contact us
    • Subscription
    • Email alert
    • Write to Australian Prescriber
  • Index
    • Subject index
    • Author index
  • Resources
    • Consumer comments
    • Patient perspectives
    • Support organisations
    • News
  • Archive
    • Back Issues
    • Media releases
    • Past covers
Volume 25 Number 5 October 2002
Editorial
Can we afford intensive management of diabetes?
(Editorial) B. Pekarsky & B. Ewald
pdf
Transparency and the Pharmaceutical Benefits Advisory Committee
L. Sansom
pdf
Letters to the Editor
pdf
Sensitivity and specificity - is your test reliable?
pdf
Experimental and clinical pharmacology
Experimental and clinical pharmacology
New drugs for colorectal cancer - mechanisms of action
L.P. Rivory
pdf
Experimental and clinical pharmacology
Experimental and clinical pharmacology
New treatments for advanced and metastatic colorectal cancer - clinical applications
S. Clarke
pdf
Perceptions of risk - a legal perspective
J. McPhee
pdf
Drug treatment of macular degeneration
R. Guymer
pdf
Patient support organisation
Retina Australia
pdf
How we write about new drugs
J.S. Dowden
pdf
New drugs
amisulpride
modafinil
peginterferon alfa-2b
reboxetine mesylate

pdf
National Prescribing Service
Medicines Line
pdf
Get Adobe Acrobat
Australian Prescriber Cover
click to download
the full PDF issue

To view and print the PDF print versions you may need to download and install Acrobat Reader by clicking on the button below

Get Adobe Acrobat

HomeHome Contact usContact us Free subscriptionFree subscription Useful linksUseful links User guideUser guide Legal informationLegal information Privacy noticePrivacy notice Web manager